D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
CALL
AerCap
AER
$24B
| $2.96M | ﹤0.01% |
63,500
+100
| +0.2% | +$4.51K |
|
1852
ASE Group
ASX
$76.5B
| $2.96M | ﹤0.01% |
685,743
+24,919
| +4% | +$97.8K |
|
|
TARO
1853
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2.95M | ﹤0.01% |
27,322
-14,523
| -35% | -$1.45M |
|
|
MYND
1854
Mynd.ai
MYND
$18.2M
| $2.95M | ﹤0.01% |
44,663
+14,208
| +47% | +$1.06M |
|
1855
Integer Holdings
ITGR
$3.42B
| $2.95M | ﹤0.01% |
39,083
+30,510
| +356% | +$2.5M |
|
1856
Packaging Corp of America
PKG
$22.2B
| $2.93M | ﹤0.01% |
29,485
-170,326
| -85% | -$16.2M |
|
1857
Workday
WDAY
$39B
| $2.93M | ﹤0.01% |
15,197
+2,717
| +22% | +$494K |
|
1858
Frontdoor
FTDR
$5.16B
| $2.93M | ﹤0.01% |
85,115
-133,615
| -61% | -$4.08M |
|
1859
CALL
Ulta Beauty
ULTA
$22.2B
| $2.93M | ﹤0.01% |
8,400
-33,300
| -80% | -$10.1M |
|
1860
CALL
Cognizant
CTSH
$24.3B
| $2.93M | ﹤0.01% |
40,400
+35,300
| +692% | +$2.47M |
|
1861
PUT
Target
TGT
$65.6B
| $2.92M | ﹤0.01% |
36,400
-150,800
| -81% | -$11M |
|
1862
CALL
Everest Group
EG
$14.5B
| $2.92M | ﹤0.01% |
13,500
-1,800
| -12% | -$392K |
|
1863
DHI Group
DHX
$176M
| $2.91M | ﹤0.01% |
1,198,470
+137,669
| +13% | +$318K |
|
1864
CALL
American Water Works
AWK
$27.2B
| $2.91M | ﹤0.01% |
+27,900
| New | +$2.74M |
|
1865
Gentherm
THRM
$1.3B
| $2.91M | ﹤0.01% |
78,886
+45,828
| +139% | +$1.87M |
|
1866
Entravision Communication
EVC
$1.07B
| $2.9M | ﹤0.01% |
895,867
+81,615
| +10% | +$302K |
|
1867
E.W. Scripps
SSP
$259M
| $2.9M | ﹤0.01% |
138,000
+54,404
| +65% | +$1.08M |
|
1868
Minerals Technologies
MTX
$2.25B
| $2.89M | ﹤0.01% |
49,203
-63,404
| -56% | -$3.62M |
|
1869
TechnipFMC
FTI
$27.5B
| $2.89M | ﹤0.01% |
+165,086
| New | +$2.79M |
|
1870
PUT
Copa Holdings
CPA
$5.8B
| $2.89M | ﹤0.01% |
35,800
-83,600
| -70% | -$7.35M |
|
1871
Akebia Therapeutics
AKBA
$362M
| $2.88M | ﹤0.01% |
351,787
-65,391
| -16% | -$449K |
|
1872
CALL
Lumen
LUMN
$6.76B
| $2.88M | ﹤0.01% |
240,000
+169,000
| +238% | +$2.35M |
|
1873
Public Storage
PSA
$59.3B
| $2.87M | ﹤0.01% |
13,180
-175,444
| -93% | -$36.7M |
|
1874
Saia
SAIA
$9.33B
| $2.87M | ﹤0.01% |
46,980
-87,883
| -65% | -$5.44M |
|
1875
First Commonwealth Financial
FCF
$2.18B
| $2.87M | ﹤0.01% |
227,634
+211,152
| +1,281% | +$2.82M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.